{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:33:38Z","timestamp":1792611218425,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.autrev.2010.08.007","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T08:49:21Z","timestamp":1281862161000},"page":"84-89","source":"Crossref","is-referenced-by-count":164,"title":["Modern diagnosis of autoimmune blistering skin diseases"],"prefix":"10.1016","volume":"10","author":[{"given":"Enno","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2010.08.007_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2010.08.007_bb0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.200.9.751","article-title":"Basement zone antibodies in bullous pemphigoid","volume":"200","author":"Jordon","year":"1967","journal-title":"Jama"},{"key":"10.1016\/j.autrev.2010.08.007_bb0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3181\/00379727-117-29622","article-title":"Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining","volume":"117","author":"Beutner","year":"1964","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.autrev.2010.08.007_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0625.2009.00948.x","article-title":"Animal models for autoimmune bullous dermatoses","volume":"19","author":"Bieber","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaut.2008.08.003","article-title":"Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity","volume":"31","author":"Culton","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2010.08.007_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2010.08.007_bb0035","doi-asserted-by":"crossref","first-page":"A379","DOI":"10.1016\/j.autrev.2009.10.009","article-title":"Geoepidemiologic considerations of auto-immune pemphigus","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2010.08.007_bb0040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.autrev.2010.08.007_bb0050","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2014incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2010.08.007_bb0055","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.131.8.957","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2133.1988.tb01747.x","article-title":"The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid","volume":"118","author":"Kelly","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0065","first-page":"1","article-title":"Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules","volume":"53","author":"Koch","year":"1990","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0070","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI113387","article-title":"Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen","volume":"81","author":"Eyre","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2010.08.007_bb0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2010.08.007_bb0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1523-1747.ep12317587","article-title":"Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent","volume":"105","author":"Amagai","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0090","series-title":"Novel ELISA systems for antibodies to desmoglein 1 and 3: Correlation of disease activity with serum autoantibody levels in individual pemphigus patients","author":"Schmidt","year":"2010"},{"key":"10.1016\/j.autrev.2010.08.007_bb0095","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0100","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/jid.2009.41","article-title":"Pathogenic anti-desmoglein MAbs show variable ELISA activity because of preferential binding of mature versus proprotein isoforms of desmoglein 3","volume":"129","author":"Sharma","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0105","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.autrev.2010.08.007_bb0115","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2010.08.007_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2007.00322.x","article-title":"Paraneoplastic pemphigus","volume":"34","author":"Zhu","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0125","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1610-0387.2010.07380.x","article-title":"Clinical and immunopathological spectrum of paraneoplastic pemphigus","volume":"8","author":"Zimmermann","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.autrev.2010.08.007_bb0130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1523-1747.2001.01263.x","article-title":"Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin","volume":"116","author":"Nagata","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0135","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.jid.5700198","article-title":"Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients","volume":"126","author":"Zhang","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2010.08.007_bb0145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2008.07.021","article-title":"Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay","volume":"129","author":"Mouquet","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0160","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0165","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2010.08.007_bb0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.1999.00497.x","article-title":"IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180","volume":"112","author":"Perriard","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0180","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.0022-202X.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Di Zenzo","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/jaut.2000.0437","article-title":"Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180","volume":"15","author":"Kromminga","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2010.08.007_bb0200","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1600-0625.2010.01080.x","article-title":"IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis","volume":"19","author":"Horvath","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0205","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0190-9622(00)90168-3","article-title":"IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity","volume":"42","author":"Dopp","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","article-title":"Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid","volume":"144","author":"Iwata","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0215","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.0022-202X.2005.23853.x","article-title":"Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid","volume":"125","author":"Fairley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2010.08.007_bb0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2003.12.007","article-title":"Development of an ELISA for the detection of autoantibodies to BP230","volume":"111","author":"Kromminga","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0230","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1523-1747.2000.00893.x","article-title":"IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230","volume":"114","author":"Skaria","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0235","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.AOG.0000115506.76104.ad","article-title":"Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis","volume":"103","author":"Sitaru","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0240","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1523-1747.1999.00622.x","article-title":"IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis","volume":"113","author":"Chimanovitch","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0245","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0250","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1542-0124(12)70281-1","article-title":"Ocular mucous membrane pemphigoid: diagnosis and management strategies","volume":"6","author":"Saw","year":"2008","journal-title":"Ocul Surf"},{"key":"10.1016\/j.autrev.2010.08.007_bb0255","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0260","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","article-title":"Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity","volume":"154","author":"Oyama","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0265","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/1523-1747.ep12292701","article-title":"Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida","volume":"108","author":"Bedane","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0270","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2133.1998.02502.x","article-title":"Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (alpha3beta3gamma2)","volume":"139","author":"Lazarova","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0275","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jaad.2004.06.004","article-title":"Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid","volume":"51","author":"Lazarova","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0280","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2010.08.007_bb0285","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.135.9.1091","article-title":"Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?","volume":"135","author":"Leverkus","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0290","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/sj.jid.5700465","article-title":"Antigen specificity in subsets of mucous membrane pemphigoid","volume":"126","author":"Rashid","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0295","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/1523-1747.ep12345782","article-title":"LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells","volume":"106","author":"Marinkovich","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0300","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1523-1747.1999.00808.x","article-title":"Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1523-1747.1999.00618.x","article-title":"Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0310","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/1523-1747.ep12349283","article-title":"A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone","volume":"106","author":"Zillikens","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0315","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1346-8138.2009.00793.x","article-title":"From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid","volume":"37","author":"Dainichi","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0320","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.4049\/jimmunol.155.11.5449","article-title":"Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid","volume":"155","author":"Liu","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0325","unstructured":"Groth S, Recke A, Vafia K, Ludwig RJ, Hashimoto T, Zillikens D, et al. Development of a simple ELISA for the detection of utoantibodies in anti-p200 pemphigoid. Br J Dermatol in press."},{"key":"10.1016\/j.autrev.2010.08.007_bb0330","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM198404193101602","article-title":"Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita","volume":"310","author":"Woodley","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2010.08.007_bb0335","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI116774","article-title":"Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa","volume":"92","author":"Lapiere","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2010.08.007_bb0340","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1523-1747.ep12285634","article-title":"Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita","volume":"108","author":"Chen","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0345","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2010.08.007_bb0350","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"Sardy","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2010.08.007_bb0355","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaad.2008.12.037","article-title":"Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2010.08.007_bb0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.autrev.2008.07.021","article-title":"Pemphigus and infectious agents","volume":"8","author":"Sagi","year":"2008","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210001643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210001643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T21:16:20Z","timestamp":1685740580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997210001643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1568997210001643"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2010.08.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}